Soluble epoxide hydrolase deficiency attenuates airway inflammation in COPD via IRE1α/JNK/AP-1 signaling pathway.
Soluble epoxide hydrolase deficiency attenuates airway inflammation in COPD via IRE1α/JNK/AP-1 signaling pathway.
复制标题
DOI:
10.1186/s12950-023-00361-y
复制
发表时间:
2023-11-01
影响因子:
5.1
通讯作者:
Yu, Ganggang
中科院分区:
文献类型:
--
作者:
Yu, Yue;Yang, Ailin;He, Xin;Wu, Bo;Wu, Yanjun;Li, Yunxiao;Nie, Shan;Xu, Bo;Wang, Haoyan;Yu, Ganggang
Soluble Epoxide Hydrolase (sEH) metabolizes anti-inflammatory epoxyeicosatrienoic acids and critically affects airway inflammation in chronic obstructive pulmonary disease (COPD). Considering the excessive endoplasmic reticulum stress is associated with the earlier onset of COPD. The role of sEH and endoplasmic reticulum stress in the pathogenesis of COPD remains unknown. 16 weeks of cigarette-exposed mice were used to detect the relationship between sEH and endoplasmic reticulum stress in COPD. Human epithelial cells were used in vitro to determine the regulation mechanism of sEH in endoplasmic reticulum stress induced by cigarette smoke. sEH deficiency helps reduce emphysema formation after smoke exposure by alleviating endoplasmic reticulum stress response. sEH deficiency effectively reverses the upregulation of phosphorylation IRE1α and JNK and the nuclear expression of AP-1, alleviating the secretion of inflammatory factors induced by cigarette smoke extract. Furthermore, the treatment with endoplasmic reticulum stress and IRE1α inhibitor downregulated cigarette smoke extract-induced sEH expression and the secretion of inflammatory factors. sEH probably alleviates airway inflammatory response and endoplasmic reticulum stress via the IRE1α/JNK/AP-1 pathway, which might attenuate lung injury caused by long-term smoking and provide a new pharmacological target for preventing and treating COPD.
登录
查看更多内容
DOI:
10.1073/pnas.2118818119
发表时间:
2022-03-01
影响因子:
11.1
作者:
Sun CP;Zhou JJ;Yu ZL;Huo XK;Zhang J;Morisseau C;Hammock BD;Ma XC
通讯作者:
Ma XC
DOI:
10.15252/embj.2021109845
发表时间:
2022-03-15
期刊:
The EMBO journal
影响因子:
--
作者:
Christianson JC;Carvalho P
通讯作者:
Carvalho P
影响因子:
7.9
作者:
Lee, Jae-Won;Kim, Mun-Ock;Lee, Su Ui
通讯作者:
Lee, Su Ui
DOI:
10.1161/hypertensionaha.121.17548
发表时间:
2021-11
期刊:
Hypertension (Dallas, Tex. : 1979)
影响因子:
--
作者:
Cui Z;Li B;Zhang Y;He J;Shi X;Wang H;Zhao Y;Yao L;Ai D;Zhang X;Zhu Y
通讯作者:
Zhu Y
DOI:
10.1084/jem.20200938
发表时间:
2021-08-02
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Hisata S;Racanelli AC;Kermani P;Schreiner R;Houghton S;Palikuqi B;Kunar B;Zhou A;McConn K;Capili A;Redmond D;Nolan DJ;Ginsberg M;Ding BS;Martinez FJ;Scandura JM;Cloonan SM;Rafii S;Choi AMK
通讯作者:
Choi AMK